Advanced search
Publication Cover
Acta Orthopaedica Scandinavica Volume 74, 2003 - Issue 6
Journal homepage
2,080
Views
310
CrossRef citations to date
0
Altmetric
Original Article

Antibiotic prophylaxis in total hip arthroplasty
Effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register

Lars Engesæter Department of Orthopedics, 1Lund University Hospital, Lund, Sweden, 2INR, Faculty of Health Sciences Linkoping, Sweden
,
Stein Atle Lie Department of Orthopedics, 1Lund University Hospital, Lund, Sweden, 2INR, Faculty of Health Sciences Linkoping, Sweden
,
Birgitte Espehaug Department of Orthopedics, 1Lund University Hospital, Lund, Sweden, 2INR, Faculty of Health Sciences Linkoping, Sweden
,
Ove Furnes Department of Orthopedics, 1Lund University Hospital, Lund, Sweden, 2INR, Faculty of Health Sciences Linkoping, Sweden
,
Stein Emil Vollset Department of Orthopedics, 1Lund University Hospital, Lund, Sweden, 2INR, Faculty of Health Sciences Linkoping, Sweden
&
Leif Ivar Havelin Department of Orthopedics, 1Lund University Hospital, Lund, Sweden, 2INR, Faculty of Health Sciences Linkoping, Sweden
Pages 644-651 | Published online: 08 Jul 2009

References

  • Bi Y, Seabold J M, Kaar S G, et al. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 2001; 16: 2082–91.
  • Chiu F-Y, Chen C-M, Lin C-F J, Lo W-H. Cefuroxime-impregnated cement in primary total knee arthroplasty. A prospective, randomized study of three hundred and forty knees. J Bone Joint Surg (Am) 2002; 84: 759–62.
  • Clarke M T, Roberts C, Gray J, Keene G S, Rushton N. Detection of bacteria in revision hip replacement surgery by PCR. J Bone Joint Surg (Br) (Suppl. IV) 2001; 83: S393–4.
  • Cox D R. Regression models and life tables (with discus-sion). J Roy Statist Soc 1972; B34: 187–220.
  • Espehaug B, Engesxter L B, Vollset S E, Havelin L I, Lan-geland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replace-ments reported to the Norwegian Arthroplasty Register, 1987-1995. J Bone Joint Surg (Br) 1997; 79: 590–5.
  • Havelin L I, Espehaug B, Lie S A, Engesxter L B, Fumes 0, Vollset S E. The Norwegian Arthroplasty Register. 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000; 71: 337–53.
  • Havelin L I, Espehaug B, Fumes 0. The Norwegian Arthroplasty Register. Yearbook 2002, Bergen, Norway.
  • Kaplan EL, Meier P. Nonparametric estimation from incom-plete observation. J Am Stat Assoc 1958; 53: 457–81.
  • Lidgren L. Joint prosthetic infections: A success story. Acta Orthop Scand 2001; 72: 553–6.
  • Malchau H, Herberts P. Prognosis of total hip replacement. Revision and re-revision rate in THR: A revision-risk study of 148,359 primary operations. Scientific exhibition presented at the 65th annual meeting of AAOS, February 19–23, 1998, New Orleans, USA.
  • Santavirta S, Takagi M, Konttinen Y T, Sorsa T, Suda A. Inhibitory effect of cephalotin on matrix metallopro-teinase activity around loose hip prostheses. Antimicrob Agents Chemother 1996; 40: 244–6.
  • SPSS Inc. SPSS Advanced Models 9.0. Chicago: SPSS Inc, 1999.
  • Spyniewska G, Lis K, Bilinski P J. Bone turnover mark-ers and cytokines in joint fluid. Analyses in 10 patients with loose hip prosthesis and 39 with coxarthrosis. Acta Orthop Scand 2002; 73: 518–22.
  • van de Belt H, Neut D, Schenk W, van Horn J R, van der Mei H C, Busscher H J. Infections of orthopaedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001; 72: 557–71.
  • Walenkamp G H I M. Prevention of infection in orthopae-dic surgery. In: European Instructional Course Lectures (Eds. Thorngren K-G, Soucacos P N, Horan F, Scott J). The British Editorial Society of Bone and Joint Surgery, London 2001; 5: 5–17.
  • Wang M L, Hauschka P V, Tuan R S, Steinbeck M J. Expo-sure to particles stimulates superoxide production by human THP-1 macrophages and avian HD-11EM osteo-clasts activated by tumor necrosis factor-alpha and PMA. J Arthroplasty 2002; 17: 335–46.
  • Wymenga A, van Horn J, Theeuwes A, Muytjens H, Sloff T. Cefuroxime for prevention of postoperative coxitis. One versus three doses tested in a randomized multicenter study of 2,651 arthroplasties. Acta Orthop Scand 1992; 63: 19–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.